Indolent thyroid cancer: knowns and unknowns.

Area of Science:

• Oncology
• Endocrinology
• Diagnostic Imaging

Background:

• Thyroid cancer incidence is increasing, largely due to the detection of indolent, clinically insignificant tumors.
• Current staging systems are inadequate for predicting indolent tumor behavior, focusing instead on prognosis after treatment.
• Predictive features for indolent thyroid cancer remain largely unstudied.

Purpose of the Study:

• To highlight the need for research into identifying clinical, radiologic, and pathologic features that predict indolent thyroid cancer behavior.
• To emphasize the limitations of existing staging systems and diagnostic tools in identifying indolent disease.
• To underscore the importance of developing methods to avoid overtreatment of thyroid cancer.

Main Methods:

• Review of existing literature on thyroid cancer detection, indolent behavior, and diagnostic modalities.
• Analysis of the limitations of current clinicopathologic staging systems.
• Evaluation of the current status and potential of ultrasound and molecular studies in predicting indolence.

Main Results:

• Increased detection of thyroid cancer is driven by identifying indolent forms.
• Clinical, radiologic, and pathologic predictors of indolent behavior are not well established.
• Ultrasound and molecular studies show early promise but require further development for definitive indolent marker identification.

Conclusions:

• Predicting indolent thyroid cancer behavior is crucial to avoid overtreatment, given the rising incidence.
• Further research into sonographic features and molecular markers is essential for identifying indolent thyroid cancer.
• Active surveillance is emerging as an alternative to surgery for indolent thyroid microcarcinoma, necessitating robust prediction protocols.